Posted on 11/13/20
Checkmate Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides an Update on Recent Progress
CAMBRIDGE, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI), a clinical stage biotechnology company focused on developing its proprietary technology to harness . . .
Posted on 11/13/20
Prevail Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights
NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative . . .
Posted on 11/13/20
Vaccinex Reports Third Quarter 2020 Financial Results and Provides Corporate Update
ROCHESTER, N.Y., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company developing innovative therapies for the treatment of neurodegenerative diseases and . . .
Posted on 11/13/20
PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
CRANBURY, N.J., Nov. 13, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic . . .
Posted on 11/13/20
AIM ImmunoTech Provides Third Quarter 2020 Business Update
OCALA, Fla., Nov. 13, 2020 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to . . .
Posted on 11/13/20
Bio-Path Holdings Reports Third Quarter 2020 Financial Results
HOUSTON, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize liposomal delivery and antisense technology to develop a . . .
Posted on 11/13/20
Shattuck Labs Reports Third Quarter 2020 Financial Results and Recent Business Highlights
AUSTIN, TX and DURHAM, NC, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional . . .
Posted on 11/13/20
Pfizer CEO Sold Shares on Same Day as the Company's Coronavirus Vaccine News: Should You Be Outraged?
This seems like another story of the greed of corporate executives, at least at first glance. On Monday, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) announced exciting news. . . .
Posted on 11/13/20
Forget Moderna: This Is a Stronger Coronavirus Stock
Moderna (NASDAQ:MRNA) could have a good chance of reporting positive news later this month from a late-stage study of coronavirus vaccine candidate mRNA-1273. Pfizer and BioNTech . . .
Posted on 11/13/20
Is CVS Health a Great Dividend Stock?
Dividend stocks can generate significant long-term returns for your portfolio by allowing you to benefit from a rising valuation while collecting recurring cash flow along the . . .
Posted on 11/13/20
Organogenesis Holdings Prices of Public Offering of Class A Common Stock
CANTON, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of . . .
Posted on 11/13/20
Keros Therapeutics Prices of Public Offering of Common Stock
LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments . . .
Posted on 11/13/20
Vesey Street Capital Partners Announces Recapitalization of QualityMetric
Vesey Street Capital Partners, LLC, a New York-based healthcare services private equity firm, announced that funds managed by VSCP have completed a recapitalization of QualityMetric, an . . .
Posted on 11/12/20
Coronavirus Recap, Nov. 5 – 12: Hospitalizations Climb, Cases Climb
The number of Marylanders currently hospitalized due to coronavirus is continuing to climb, reaching a recent high of 863 on Thursday.That is the highest number of . . .
Posted on 11/12/20
TYME Provides Business Update and Announces Second Quarter Fiscal 2021 Financial and Operating Results
BEDMINSTER, N.J.--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced financial and operating results for its second quarter ended . . .
Posted on 11/12/20
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein . . .
Posted on 11/12/20
Axcella Reports Third Quarter 2020 Financial Results and Provides Business Update
AMBRIDGE, Mass.--(BUSINESS WIRE)--Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions, . . .
Posted on 11/12/20
Akers Biosciences and MyMD Pharmaceuticals Merges
MyMD Pharmaceuticals, Inc. and Akers Biosciences, Inc. (NASDAQ: AKER) today jointly announced that they have entered into a definitive merger agreement.
Posted on 11/12/20
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2020 Financial Results
LEXINGTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel . . .
Posted on 11/12/20
Viela Bio Reports Third Quarter 2020 Financial Results and Program Highlights
GAITHERSBURG, Md., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune . . .
Posted on 11/12/20
Eyenovia Reports Third Quarter 2020 Financial Results
NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc., (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print therapeutics, . . .
Posted on 11/12/20
Osmotica Pharmaceuticals plc Reports Third Quarter 2020 Results and Provides Business Updates
BRIDGEWATER, N. J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced business highlights and financial results . . .
Posted on 11/12/20
Clearside Biomedical Announces Third Quarter 2020 Financial Results and Provides Corporate Update
ALPHARETTA, Ga., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision . . .
Posted on 11/12/20
Acer Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
NEWTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for . . .
Posted on 11/12/20
Keros Therapeutics Proposed Public Offering of Common Stock
LEXINGTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel . . .

